(Q37894986)

24 August 2017

1 reference

title

The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review (English)

1 reference

24 August 2017

1 reference

1 reference

Davide Tassinari

1

1 reference

24 August 2017

Fabrizio Drudi

2

1 reference

24 August 2017

Marta Rosati

3

1 reference

24 August 2017

Paola Tombesi

4

1 reference

24 August 2017

Sergio Sartori

5

1 reference

24 August 2017

Marco Maltoni

6

1 reference

24 August 2017

1 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

25

1 reference

24 August 2017

5

1 reference

24 August 2017

410-423

1 reference

A validation study of the WHO method for cancer pain relief

24 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Argentina's WHO Cancer Pain Relief Program: a patient care model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Strategies to manage the adverse effects of oral morphine: an evidence-based report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Low morphine doses in opioid-naive cancer patients with pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Use of strong opioids in advanced cancer pain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

A validation study of the WHO analgesic ladder: a two-step vs three-step strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

The role of tramadol in cancer pain treatment--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Going from evidence to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Progress in evidence-based medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

High-dose tramadol in comparison to low-dose morphine for cancer pain relief.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311405090

21 January 2018

Identifiers

DOI

10.1177/0269216311405090

1 reference

24 August 2017

1 reference